Extracorporeal Endotoxin Removal


PMX is a Polymyxin B extracorporeal direct hemoperfusion adsorption column which is highly effective in removing endotoxin in the bloodstream.

  • Clinically available since 1995*
  • More than 340,000 treatments performed worldwide 
  • Reproducible clinical benefits
  • As of 2019, more than 200 scientific papers and peer reviewed articles available


Clinical Benefits
Click to Hide Advanced Floating Content
EAA™ and PMX are licensed and available for use in Canada. PMX is not approved for clinical use in the USA, and is currently undergoing the PMA (Premarket approval) process. EAA™ is FDA cleared for use in the USA. The information presented herein is region specific. Please contact Spectral Medical Inc.to obtain appropriate product information for your country.